Search research articles
Contact Us
Filters
Showing results (11-20 of 207) with videos related to
Page
of 21
Sort By:
JAMA Internal Medicine
|
June 6, 2018
Should Metformin Be First-line Therapy for Patients With Type 2 Diabetes and Chronic Kidney Disease?: Informed Patients Should Decide
Chester B Good, Leonard M Pogach
JAMA Network Open
|
July 18, 2024
Access and Safety-The FDA Drug Approval Conundrum
Chester B Good, Samuel K Peasah
JAMA
|
October 24, 2019
Adalimumab and the Challenges for Biosimilars
Walid F Gellad, Chester B Good
JAMA Internal Medicine
|
November 3, 2015
Off-label Drug Use and Adverse Drug Events: Turning up the Heat on Off-label Prescribing
Chester B Good, Walid F Gellad
JAMA Internal Medicine
|
July 2, 2016
Prescription of Brand-Name Medications When Generic Alternatives Are Available-Patently Unfair
Walid F Gellad, Chester B Good
The American Journal of Medicine
|
September 17, 2005
The Vioxx debacle revisited
Chester B Good, Catherine L Kelley
Journal of General Internal Medicine
|
June 5, 2020
Interpreting COVID-19 Test Results: a Bayesian Approach
Chester B Good, Inmaculada Hernandez, Kenneth Smith
BMC Medicine
|
December 19, 2018
Avoiding rash decisions about zoster vaccination: insights from cost-effectiveness evidence
Chester B Good, Natasha Parekh, Inmaculada Hernandez
Annals of Internal Medicine
|
July 2, 2019
Statins for Primary Prevention of Cardiovascular Disease
Chester B Good, Inmaculada Hernandez, Natasha Parekh
JAMA Internal Medicine
|
November 27, 2013
Topical anesthetic-induced methemoglobinemia and veterans affairs hospitals
Chester B Good, Muriel Burk, Francesca Cunningham
Page
of 21
Search research articles
Search
Showing results (11-20 of 207) with videos related to
Sort By:
Page
of 21
JAMA Internal Medicine
|
June 6, 2018
Should Metformin Be First-line Therapy for Patients With Type 2 Diabetes and Chronic Kidney Disease?: Informed Patients Should Decide
Chester B Good, Leonard M Pogach
JAMA Network Open
|
July 18, 2024
Access and Safety-The FDA Drug Approval Conundrum
Chester B Good, Samuel K Peasah
JAMA
|
October 24, 2019
Adalimumab and the Challenges for Biosimilars
Walid F Gellad, Chester B Good
JAMA Internal Medicine
|
November 3, 2015
Off-label Drug Use and Adverse Drug Events: Turning up the Heat on Off-label Prescribing
Chester B Good, Walid F Gellad
JAMA Internal Medicine
|
July 2, 2016
Prescription of Brand-Name Medications When Generic Alternatives Are Available-Patently Unfair
Walid F Gellad, Chester B Good
The American Journal of Medicine
|
September 17, 2005
The Vioxx debacle revisited
Chester B Good, Catherine L Kelley
Journal of General Internal Medicine
|
June 5, 2020
Interpreting COVID-19 Test Results: a Bayesian Approach
Chester B Good, Inmaculada Hernandez, Kenneth Smith
BMC Medicine
|
December 19, 2018
Avoiding rash decisions about zoster vaccination: insights from cost-effectiveness evidence
Chester B Good, Natasha Parekh, Inmaculada Hernandez
Annals of Internal Medicine
|
July 2, 2019
Statins for Primary Prevention of Cardiovascular Disease
Chester B Good, Inmaculada Hernandez, Natasha Parekh
JAMA Internal Medicine
|
November 27, 2013
Topical anesthetic-induced methemoglobinemia and veterans affairs hospitals
Chester B Good, Muriel Burk, Francesca Cunningham
Page
of 21